Sign in

CIK 0001764013

  • Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
832771572
Phone
+1 917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$895,852
in 9 filings, $173K under 10b5-1 plans

Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-04-24 Levine Mark S. Chief Legal Officer Sale −3,963 $28.90 $115K 343,156
2024-04-17 Levine Mark S. Chief Legal Officer Sale −7,602 $28.80 $219K 349,344
2024-04-17 Levine Mark S. Chief Legal Officer Sale −2,225 $29.94 $67K 347,119
2024-04-17 Macias William L. Chief Medical Officer Sale −6,136 $28.80 $177K 379,794
2024-04-17 Macias William L. Chief Medical Officer Sale −1,796 $29.94 $54K 377,998
2024-04-17 Macias William L. Chief Medical Officer Sale −269 $28.80 $8K 377,729
2024-04-17 Macias William L. Chief Medical Officer Sale −79 $29.94 $2K 377,650
2024-04-17 Barnett Eva Renee Chief Financial Officer Sale −9,479 $28.80 $273K 362,230
2024-04-17 Barnett Eva Renee Chief Financial Officer Sale −2,774 $29.94 $83K 359,456
2024-04-17 Butchko Julia G. Chief Development Officer Sale −7,825 $28.80 $225K 453,917
2024-04-17 Butchko Julia G. Chief Development Officer Sale −2,290 $29.94 $69K 451,627
2024-04-17 Salzmann Peter Chief Executive Officer Sale −26,365 $28.80 $759K 1,060,593
2024-04-17 Salzmann Peter Chief Executive Officer Sale −7,714 $29.94 $231K 1,052,879
2024-04-09 Barnett Eva Renee Chief Financial Officer Sale −3,689 $31.18 $115K 371,709
2024-04-09 Butchko Julia G. Chief Development Officer Sale −1,053 $31.18 $33K 461,742
2024-04-09 Salzmann Peter Chief Executive Officer Sale −4,807 $31.18 $150K 1,086,958
2024-04-02 Fromkin Andrew J. Director Grant or award +11,255 99,913
2024-04-02 Fromkin Andrew J. Director Grant or award · Stock Option (right to buy) +4,690 4,690
2024-04-02 Hughes Douglas J. Director Grant or award +11,255 125,010
2024-04-02 Hughes Douglas J. Director Grant or award · Stock Option (right to buy) +4,690 4,690

Page 13 of 18 · 351 trades